FDA Proposes “Sinusitis” Exclusion From OTC Nasal Decongestant Monograph

FDA is seeking to amend the OTC nasal decongestant monograph by removing the indications that reference "sinusitis," the agency announced in a proposed rule slated for publication in the Aug. 2 Federal Register